Gene Synthesis Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 2 Business Days
Gene Synthesis Market Growth & Trends
The global gene synthesis market size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.
The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in December 2020, Evonetix Ltd. entered into a research collaboration with Analog Devices, Inc. Under the terms of the agreement, the companies collaborated on Evonetix's Microelectromechanical System-based silicon chips' improvement and commercial scale-up, as well as the development of a DNA desktop writer.
Researchers, as well as biotechnology and pharmaceutical corporations, have become increasingly interested in targeted therapy during recent years. It has become a popular method of disease management. In the near future, targeted therapy in conjunction with chemotherapy and immunotherapy is likely to develop significantly, presenting lucrative prospects for both emerging & established competitors in the gene synthesis market.
Key players are focusing on product development and are entering into partnerships and collaborations to expand their product offerings. For instance, In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, Inc.- a producer of antibodies and vectors. This acquisition may help the company strengthen its position in the market. Similarly, in July 2021, GenScript hosted the GenScript Gene & Cell Engineering Virtual Summit. This event focused on highlighting synthetic biology research to enhance protein design, drug discovery, and genome editing, enabling the company to increase its customer base.
Gene Synthesis Market Report Highlights
Gene Synthesis Market Growth & Trends
The global gene synthesis market size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.
The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in December 2020, Evonetix Ltd. entered into a research collaboration with Analog Devices, Inc. Under the terms of the agreement, the companies collaborated on Evonetix's Microelectromechanical System-based silicon chips' improvement and commercial scale-up, as well as the development of a DNA desktop writer.
Researchers, as well as biotechnology and pharmaceutical corporations, have become increasingly interested in targeted therapy during recent years. It has become a popular method of disease management. In the near future, targeted therapy in conjunction with chemotherapy and immunotherapy is likely to develop significantly, presenting lucrative prospects for both emerging & established competitors in the gene synthesis market.
Key players are focusing on product development and are entering into partnerships and collaborations to expand their product offerings. For instance, In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, Inc.- a producer of antibodies and vectors. This acquisition may help the company strengthen its position in the market. Similarly, in July 2021, GenScript hosted the GenScript Gene & Cell Engineering Virtual Summit. This event focused on highlighting synthetic biology research to enhance protein design, drug discovery, and genome editing, enabling the company to increase its customer base.
Gene Synthesis Market Report Highlights
- The growth is attributed to the growing demand for the synthetic biology, coupled with increasing government support to offer funds for R&D initiatives in synthetic biology
- By method, solid-phase synthesis dominated in 2022 as it offers high accuracy and is a prominent technology for the applications in several fields and for various research purposes
- By services, antibody DNA synthesis dominated the gene synthesis market in 2022, owing to the presence of significant players such as Synbio offers services, Twist Bioscience Corporation, and others, offering services in this segment
- By application, the gene & cell therapy development segment dominated the gene synthesis market in 2022. This is attributed to the growing number of R&D programs for the development of cell and gene therapies
- By end-use, academic and government research institute dominated the gene synthesis market in 2022, as most of the gene synthesis process is performed in the research settings for clinical research and investigational programs
- North America captured the highest share in 2022 owing to the well-established molecular biology infrastructure along with the presence of a significant number of market players in the region
CHAPTER 1 GENE SYNTHESIS MARKET: METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
1.7 Global Market: CAGR Calculation
1.8 Regional Market: CAGR Calculation
1.9 List Of Secondary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
1.11 List of Abbreviations
CHAPTER 2 GENE SYNTHESIS MARKET: EXECUTIVE SUMMARY
2.1 Gene Synthesis Market: Market Outlook
2.1.1 Market Summary
CHAPTER 3 GENE SYNTHESIS MARKET: INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Rising investment in synthetic biology market
3.3.1.2 Advent of enzymatic DNA synthesis process
3.3.1.3 Technological advancements in the DNA synthesis platforms
3.3.1.4 Declining price of DNA synthesis & sequencing
3.3.2 Market restraint Analysis
3.3.2.1 Lack of skilled professionals
3.3.2.2 Misuse of gene synthesis
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
CHAPTER 4 GENE SYNTHESIS MARKET: COMPETITIVE LANDSCAPE
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
CHAPTER 5 GENE SYNTHESIS MARKET: METHOD BUSINESS ANALYSIS
5.1 Gene Synthesis Market: Method Movement Analysis
5.2 Solid-phase Synthesis
5.2.1 Solid-phase Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Chip-based Synthesis
5.3.1 Chip-based Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
5.4 PCR-based Enzyme Synthesis
5.4.1 PCR-based Enzyme Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 GENE SYNTHESIS MARKET: SERVICES BUSINESS ANALYSIS
6.1 Gene Synthesis Market: Services Movement Analysis
6.2 Antibody DNA Synthesis
6.2.1 Antibody DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Viral DNA Synthesis
6.3.1 Viral DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 GENE SYNTHESIS MARKET: APPLICATION BUSINESS ANALYSIS
7.1 Gene Synthesis Market: Application Movement Analysis
7.2 Gene & Cell Therapy Development
7.2.1 Gene & Cell Therapy Development market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Vaccine Development
7.3.1 Vaccine Development market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Disease Diagnosis
7.4.1 Disease Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
7.5 Others
7.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 GENE SYNTHESIS MARKET: END-USE BUSINESS ANALYSIS
8.1 Gene Synthesis Market: End-use Movement Analysis
8.2 Biotechnology and Pharmaceutical Companies
8.2.1 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030 (USD Million)
8.3 Academic and Government Research Institutes
8.3.1 Academic And Government Research Institutes market estimates and forecast, 2018 - 2030 (USD Million)
8.4 Contract Research Organizations
8.4.1 Contract Research Organizations market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 GENE SYNTHESIS MARKET: REGIONAL BUSINESS ANALYSIS
9.1 North America
9.1.1 Swot Analysis
9.1.1.1 North America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.1.2 U.S.
9.1.2.1 Key Country Dynamics
9.1.2.2 Target Disease Prevalence
9.1.2.3 Competitive Scenario
9.1.2.4 Regulatory Framework
9.1.2.5 Reimbursement Scenario
9.1.2.6 U.S. Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.1.3 CANADA
9.1.3.1 Key Country Dynamics
9.1.3.2 Target Disease Prevalence
9.1.3.3 Competitive Scenario
9.1.3.4 Regulatory Framework
9.1.3.5 Reimbursement Scenario
9.1.3.6 Canada Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2 Europe
9.2.1 SWOT Analysis:
9.2.1.1 Europe Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2 Germany
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 Competitive Scenario
9.2.2.4 Regulatory Framework
9.2.2.5 Reimbursement Scenario
9.2.2.6 Germany Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3 UK
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Competitive Scenario
9.2.3.4 Regulatory Framework
9.2.3.5 Reimbursement Scenario
9.2.3.6 UK Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4 FRANCE
9.2.4.1 Key Country Dynamics
9.2.4.2 Target Disease Prevalence
9.2.4.3 Competitive Scenario
9.2.4.4 Regulatory Framework
9.2.4.5 Reimbursement Scenario
9.2.4.6 France Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.5 Italy
9.2.5.1 Key Country Dynamics
9.2.5.2 Target Disease Prevalence
9.2.5.3 Competitive Scenario
9.2.5.4 Regulatory Framework
9.2.5.5 Reimbursement Scenario
9.2.5.6 Italy Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.6 Spain
9.2.6.1 Key Country Dynamics
9.2.6.2 Target Disease Prevalence
9.2.6.3 Competitive Scenario
9.2.6.4 Regulatory Framework
9.2.6.5 Reimbursement Scenario
9.2.6.6 Spain Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.7 Denmark
9.2.7.1 Key Country Dynamics
9.2.7.2 Target Disease Prevalence
9.2.7.3 Competitive Scenario
9.2.7.4 Regulatory Framework
9.2.7.5 Reimbursement Scenario
9.2.7.6 Denmark Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.8 Sweden
9.2.8.1 Key Country Dynamics
9.2.8.2 Target Disease Prevalence
9.2.8.3 Competitive Scenario
9.2.8.4 Regulatory Framework
9.2.8.5 Reimbursement Scenario
9.2.8.6 Sweden Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.9 Norway
9.2.9.1 Key Country Dynamics
9.2.9.2 Target Disease Prevalence
9.2.9.3 Competitive Scenario
9.2.9.4 Regulatory Framework
9.2.9.5 Reimbursement Scenario
9.2.9.6 Norway Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3 Asia Pacific
9.3.1 Swot Analysi:
9.3.1.1 Key Region Dynamics
9.3.1.2 Asia Pacific Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2 Japan
9.3.2.1 Target Disease Prevalence
9.3.2.2 Competitive Scenario
9.3.2.3 Regulatory Framework
9.3.2.4 Reimbursement Scenario
9.3.2.5 Japan Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3 China
9.3.3.1 Target Disease Prevalence
9.3.3.2 Competitive Scenario
9.3.3.3 Regulatory Framework
9.3.3.4 Reimbursement Scenario
9.3.3.5 China Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4 India
9.3.4.1 Target Disease Prevalence
9.3.4.2 Competitive Scenario
9.3.4.3 Regulatory Framework
9.3.4.4 Reimbursement Scenario
9.3.4.5 India Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5 South Korea
9.3.5.1 Target Disease Prevalence
9.3.5.2 Competitive Scenario
9.3.5.3 Regulatory Framework
9.3.5.4 Reimbursement Scenario
9.3.5.5 South Korea Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6 Australia
9.3.6.1 Target Disease Prevalence
9.3.6.2 Competitive Scenario
9.3.6.3 Regulatory Framework
9.3.6.4 Reimbursement Scenario
9.3.6.5 Australia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7 Thailand
9.3.7.1 Target Disease Prevalence
9.3.7.2 Competitive Scenario
9.3.7.3 Regulatory Framework
9.3.7.4 Reimbursement Scenario
9.3.7.5 Thailand Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4 Latin America
9.4.1 Swot Analysis:
9.4.2 Key Regional Dynamics
9.4.2.1 Latin America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3 Brazil
9.4.3.1 Target Disease Prevalence
9.4.3.2 Competitive Scenario
9.4.3.3 Regulatory Framework
9.4.3.4 Reimbursement Scenario
9.4.3.5 Brazil Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4 Mexico
9.4.4.1 Target Disease Prevalence
9.4.4.2 Competitive Scenario
9.4.4.3 Regulatory Framework
9.4.4.4 Reimbursement Scenario
9.4.4.5 Mexico Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5 Argentina
9.4.5.1 Target Disease Prevalence
9.4.5.2 Competitive Scenario
9.4.5.3 Regulatory Framework
9.4.5.4 Reimbursement Scenario
9.4.5.5 Argentina Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5 Middle East & Africa (MEA)
9.5.1 SWOT ANALYSIS:
9.5.2 KEY regional DYNAMICS
9.5.2.1 Middle East & Africa Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3 SOUTH AFRICA
9.5.3.1 Target Disease Prevalence
9.5.3.2 Competitive Scenario
9.5.3.3 Regulatory Framework
9.5.3.4 Reimbursement Scenario
9.5.3.5 south Africail Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.4 Saudi Arabia
9.5.4.1 Target Disease Prevalence
9.5.4.2 Competitive Scenario
9.5.4.3 Regulatory Framework
9.5.4.4 Reimbursement Scenario
9.5.4.5 Saudi Arabia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.5 UAE
9.5.5.1 Target Disease Prevalence
9.5.5.2 Competitive Scenario
9.5.5.3 Regulatory Framework
9.5.5.4 Reimbursement Scenario
9.5.5.5 UAE Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.6 Kuwait
9.5.6.1 Target Disease Prevalence
9.5.6.2 Competitive Scenario
9.5.6.3 Regulatory Framework
9.5.6.4 Reimbursement Scenario
9.5.6.5 Kuwait Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10 GENE SYNTHESIS MARKET: COMPANY PROFILING
10.1 Company Profiles
10.1.1 GenScript
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Brooks Automation, Inc. (GENEWIZ)
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Boster Biological Technology
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 Twist Bioscience
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 ProteoGenix, Inc.
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Biomatik
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 ProMab Biotechnologies, Inc.
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Thermo Fisher Scientific, Inc.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 Integrated DNA Technologies, Inc.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 OriGene Technologies, Inc.
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.2 List of Other Key Players
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
1.7 Global Market: CAGR Calculation
1.8 Regional Market: CAGR Calculation
1.9 List Of Secondary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
1.11 List of Abbreviations
CHAPTER 2 GENE SYNTHESIS MARKET: EXECUTIVE SUMMARY
2.1 Gene Synthesis Market: Market Outlook
2.1.1 Market Summary
CHAPTER 3 GENE SYNTHESIS MARKET: INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Rising investment in synthetic biology market
3.3.1.2 Advent of enzymatic DNA synthesis process
3.3.1.3 Technological advancements in the DNA synthesis platforms
3.3.1.4 Declining price of DNA synthesis & sequencing
3.3.2 Market restraint Analysis
3.3.2.1 Lack of skilled professionals
3.3.2.2 Misuse of gene synthesis
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
CHAPTER 4 GENE SYNTHESIS MARKET: COMPETITIVE LANDSCAPE
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
CHAPTER 5 GENE SYNTHESIS MARKET: METHOD BUSINESS ANALYSIS
5.1 Gene Synthesis Market: Method Movement Analysis
5.2 Solid-phase Synthesis
5.2.1 Solid-phase Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Chip-based Synthesis
5.3.1 Chip-based Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
5.4 PCR-based Enzyme Synthesis
5.4.1 PCR-based Enzyme Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 GENE SYNTHESIS MARKET: SERVICES BUSINESS ANALYSIS
6.1 Gene Synthesis Market: Services Movement Analysis
6.2 Antibody DNA Synthesis
6.2.1 Antibody DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Viral DNA Synthesis
6.3.1 Viral DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 GENE SYNTHESIS MARKET: APPLICATION BUSINESS ANALYSIS
7.1 Gene Synthesis Market: Application Movement Analysis
7.2 Gene & Cell Therapy Development
7.2.1 Gene & Cell Therapy Development market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Vaccine Development
7.3.1 Vaccine Development market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Disease Diagnosis
7.4.1 Disease Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
7.5 Others
7.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 GENE SYNTHESIS MARKET: END-USE BUSINESS ANALYSIS
8.1 Gene Synthesis Market: End-use Movement Analysis
8.2 Biotechnology and Pharmaceutical Companies
8.2.1 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030 (USD Million)
8.3 Academic and Government Research Institutes
8.3.1 Academic And Government Research Institutes market estimates and forecast, 2018 - 2030 (USD Million)
8.4 Contract Research Organizations
8.4.1 Contract Research Organizations market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 GENE SYNTHESIS MARKET: REGIONAL BUSINESS ANALYSIS
9.1 North America
9.1.1 Swot Analysis
9.1.1.1 North America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.1.2 U.S.
9.1.2.1 Key Country Dynamics
9.1.2.2 Target Disease Prevalence
9.1.2.3 Competitive Scenario
9.1.2.4 Regulatory Framework
9.1.2.5 Reimbursement Scenario
9.1.2.6 U.S. Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.1.3 CANADA
9.1.3.1 Key Country Dynamics
9.1.3.2 Target Disease Prevalence
9.1.3.3 Competitive Scenario
9.1.3.4 Regulatory Framework
9.1.3.5 Reimbursement Scenario
9.1.3.6 Canada Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2 Europe
9.2.1 SWOT Analysis:
9.2.1.1 Europe Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2 Germany
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 Competitive Scenario
9.2.2.4 Regulatory Framework
9.2.2.5 Reimbursement Scenario
9.2.2.6 Germany Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3 UK
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Competitive Scenario
9.2.3.4 Regulatory Framework
9.2.3.5 Reimbursement Scenario
9.2.3.6 UK Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4 FRANCE
9.2.4.1 Key Country Dynamics
9.2.4.2 Target Disease Prevalence
9.2.4.3 Competitive Scenario
9.2.4.4 Regulatory Framework
9.2.4.5 Reimbursement Scenario
9.2.4.6 France Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.5 Italy
9.2.5.1 Key Country Dynamics
9.2.5.2 Target Disease Prevalence
9.2.5.3 Competitive Scenario
9.2.5.4 Regulatory Framework
9.2.5.5 Reimbursement Scenario
9.2.5.6 Italy Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.6 Spain
9.2.6.1 Key Country Dynamics
9.2.6.2 Target Disease Prevalence
9.2.6.3 Competitive Scenario
9.2.6.4 Regulatory Framework
9.2.6.5 Reimbursement Scenario
9.2.6.6 Spain Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.7 Denmark
9.2.7.1 Key Country Dynamics
9.2.7.2 Target Disease Prevalence
9.2.7.3 Competitive Scenario
9.2.7.4 Regulatory Framework
9.2.7.5 Reimbursement Scenario
9.2.7.6 Denmark Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.8 Sweden
9.2.8.1 Key Country Dynamics
9.2.8.2 Target Disease Prevalence
9.2.8.3 Competitive Scenario
9.2.8.4 Regulatory Framework
9.2.8.5 Reimbursement Scenario
9.2.8.6 Sweden Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.9 Norway
9.2.9.1 Key Country Dynamics
9.2.9.2 Target Disease Prevalence
9.2.9.3 Competitive Scenario
9.2.9.4 Regulatory Framework
9.2.9.5 Reimbursement Scenario
9.2.9.6 Norway Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3 Asia Pacific
9.3.1 Swot Analysi:
9.3.1.1 Key Region Dynamics
9.3.1.2 Asia Pacific Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2 Japan
9.3.2.1 Target Disease Prevalence
9.3.2.2 Competitive Scenario
9.3.2.3 Regulatory Framework
9.3.2.4 Reimbursement Scenario
9.3.2.5 Japan Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3 China
9.3.3.1 Target Disease Prevalence
9.3.3.2 Competitive Scenario
9.3.3.3 Regulatory Framework
9.3.3.4 Reimbursement Scenario
9.3.3.5 China Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4 India
9.3.4.1 Target Disease Prevalence
9.3.4.2 Competitive Scenario
9.3.4.3 Regulatory Framework
9.3.4.4 Reimbursement Scenario
9.3.4.5 India Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5 South Korea
9.3.5.1 Target Disease Prevalence
9.3.5.2 Competitive Scenario
9.3.5.3 Regulatory Framework
9.3.5.4 Reimbursement Scenario
9.3.5.5 South Korea Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6 Australia
9.3.6.1 Target Disease Prevalence
9.3.6.2 Competitive Scenario
9.3.6.3 Regulatory Framework
9.3.6.4 Reimbursement Scenario
9.3.6.5 Australia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7 Thailand
9.3.7.1 Target Disease Prevalence
9.3.7.2 Competitive Scenario
9.3.7.3 Regulatory Framework
9.3.7.4 Reimbursement Scenario
9.3.7.5 Thailand Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4 Latin America
9.4.1 Swot Analysis:
9.4.2 Key Regional Dynamics
9.4.2.1 Latin America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3 Brazil
9.4.3.1 Target Disease Prevalence
9.4.3.2 Competitive Scenario
9.4.3.3 Regulatory Framework
9.4.3.4 Reimbursement Scenario
9.4.3.5 Brazil Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4 Mexico
9.4.4.1 Target Disease Prevalence
9.4.4.2 Competitive Scenario
9.4.4.3 Regulatory Framework
9.4.4.4 Reimbursement Scenario
9.4.4.5 Mexico Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5 Argentina
9.4.5.1 Target Disease Prevalence
9.4.5.2 Competitive Scenario
9.4.5.3 Regulatory Framework
9.4.5.4 Reimbursement Scenario
9.4.5.5 Argentina Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5 Middle East & Africa (MEA)
9.5.1 SWOT ANALYSIS:
9.5.2 KEY regional DYNAMICS
9.5.2.1 Middle East & Africa Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3 SOUTH AFRICA
9.5.3.1 Target Disease Prevalence
9.5.3.2 Competitive Scenario
9.5.3.3 Regulatory Framework
9.5.3.4 Reimbursement Scenario
9.5.3.5 south Africail Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.4 Saudi Arabia
9.5.4.1 Target Disease Prevalence
9.5.4.2 Competitive Scenario
9.5.4.3 Regulatory Framework
9.5.4.4 Reimbursement Scenario
9.5.4.5 Saudi Arabia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.5 UAE
9.5.5.1 Target Disease Prevalence
9.5.5.2 Competitive Scenario
9.5.5.3 Regulatory Framework
9.5.5.4 Reimbursement Scenario
9.5.5.5 UAE Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.6 Kuwait
9.5.6.1 Target Disease Prevalence
9.5.6.2 Competitive Scenario
9.5.6.3 Regulatory Framework
9.5.6.4 Reimbursement Scenario
9.5.6.5 Kuwait Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10 GENE SYNTHESIS MARKET: COMPANY PROFILING
10.1 Company Profiles
10.1.1 GenScript
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Brooks Automation, Inc. (GENEWIZ)
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Boster Biological Technology
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 Twist Bioscience
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 ProteoGenix, Inc.
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Biomatik
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 ProMab Biotechnologies, Inc.
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Thermo Fisher Scientific, Inc.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 Integrated DNA Technologies, Inc.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 OriGene Technologies, Inc.
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.2 List of Other Key Players
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 4 Global Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 5 Global Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 6 Global Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 7 Global Gene Synthesis Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 10 North America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 11 North America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 12 North America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 13 U.S. Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 14 U.S. Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 15 U.S. Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 17 Canada Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 18 Canada Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 19 Canada Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 20 Canada Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 21 Europe Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 23 Europe Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 24 Europe Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 25 Europe Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 26 Germany Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 27 Germany Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 28 Germany Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 29 Germany Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 30 UK Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 31 UK Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 32 UK Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 33 UK Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 34 France Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 35 France Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 36 France Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 37 France Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 38 Italy Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 39 Italy Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 40 Italy Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 41 Italy Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 42 Spain Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 43 Spain Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 44 Spain Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 45 Spain Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 46 Denmark Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 47 Denmark Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 48 Denmark Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 49 Denmark Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 50 Sweden Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 51 Sweden Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 52 Sweden Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 53 Sweden Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 54 Norway Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 55 Norway Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 56 Norway Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 57 Norway Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 63 China Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 64 China Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 65 China Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 66 China Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 67 Japan Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 68 Japan Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 69 Japan Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 70 Japan Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 71 India Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 72 India Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 73 India Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 74 India Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 75 Australia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 76 Australia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 77 Australia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 78 Australia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 79 Thailand Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 80 Thailand Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 81 Thailand Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 82 Thailand Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 83 South Korea Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 84 South Korea Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 85 South Korea Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 86 South Korea Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 87 Latin America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 88 Latin America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 89 Latin America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 90 Latin America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 91 Latin America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 92 Brazil Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 93 Brazil Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 94 Brazil Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 95 Brazil Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 96 Mexico Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 97 Mexico Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 98 Mexico Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 99 Mexico Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 100 Argentina Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 101 Argentina Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 102 Argentina Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 103 Argentina Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 109 South Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 110 South Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 111 South Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 112 South Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 117 UAE Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 118 UAE Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 119 UAE Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 120 UAE Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 121 Kuwait Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 122 Kuwait Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 123 Kuwait Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 124 Kuwait Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 4 Global Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 5 Global Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 6 Global Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 7 Global Gene Synthesis Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 10 North America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 11 North America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 12 North America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 13 U.S. Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 14 U.S. Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 15 U.S. Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 17 Canada Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 18 Canada Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 19 Canada Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 20 Canada Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 21 Europe Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 23 Europe Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 24 Europe Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 25 Europe Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 26 Germany Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 27 Germany Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 28 Germany Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 29 Germany Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 30 UK Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 31 UK Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 32 UK Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 33 UK Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 34 France Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 35 France Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 36 France Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 37 France Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 38 Italy Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 39 Italy Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 40 Italy Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 41 Italy Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 42 Spain Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 43 Spain Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 44 Spain Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 45 Spain Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 46 Denmark Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 47 Denmark Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 48 Denmark Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 49 Denmark Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 50 Sweden Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 51 Sweden Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 52 Sweden Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 53 Sweden Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 54 Norway Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 55 Norway Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 56 Norway Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 57 Norway Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 63 China Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 64 China Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 65 China Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 66 China Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 67 Japan Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 68 Japan Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 69 Japan Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 70 Japan Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 71 India Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 72 India Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 73 India Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 74 India Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 75 Australia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 76 Australia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 77 Australia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 78 Australia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 79 Thailand Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 80 Thailand Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 81 Thailand Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 82 Thailand Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 83 South Korea Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 84 South Korea Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 85 South Korea Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 86 South Korea Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 87 Latin America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 88 Latin America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 89 Latin America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 90 Latin America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 91 Latin America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 92 Brazil Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 93 Brazil Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 94 Brazil Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 95 Brazil Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 96 Mexico Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 97 Mexico Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 98 Mexico Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 99 Mexico Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 100 Argentina Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 101 Argentina Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 102 Argentina Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 103 Argentina Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 109 South Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 110 South Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 111 South Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 112 South Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 117 UAE Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 118 UAE Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 119 UAE Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 120 UAE Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
Table 121 Kuwait Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
Table 122 Kuwait Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
Table 123 Kuwait Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
Table 124 Kuwait Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain - Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Gene Synthesis, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Gene Synthesis Market, : Method Movement Analysis
Fig. 17 Global Gene Synthesis Market, for Solid - phase Synthesis, 2018 - 2030 (USD Million)
Fig. 18 Global Gene Synthesis Market, for Chip - based Synthesis, 2018 - 2030 (USD Million)
Fig. 19 Global Gene Synthesis Market, for PCR - based Enzyme Synthesis, 2018 - 2030 (USD Million)
Fig. 20 Global Gene Synthesis Market, for Services, Movement Analysis
Fig. 21 Global Gene Synthesis Market, for Antibody DNA Synthesis, 2018 - 2030 (USD Million)
Fig. 22 Global Gene Synthesis Market, for Viral DNA Synthesis, 2018 - 2030 (USD Million)
Fig. 23 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
Fig. 24 Global Gene Synthesis Market, for Application, Movement Analysis
Fig. 25 Global Gene Synthesis Market, for Gene & Cell Therapy Development, 2018 - 2030 (USD Million)
Fig. 26 Global Gene Synthesis Market, for Vaccine Development, 2018 - 2030 (USD Million)
Fig. 27 Global Gene Synthesis Market, for Disease Diagnosis, 2018 - 2030 (USD Million)
Fig. 28 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
Fig. 29 Global Gene Synthesis Market, for End - use, Movement Analysis
Fig. 30 Global Gene Synthesis Market, for Biotechnology and pharmaceutical companies, 2018 - 2030 (USD Million)
Fig. 31 Global Gene Synthesis Market, for Academic and government research institutes, 2018 - 2030 (USD Million)
Fig. 32 Global Gene Synthesis Market, for Contract research organizations, 2018 - 2030 (USD Million)
Fig. 33 Regional Marketplace: Key Takeaways
Fig. 34 Regional Outlook, 2022 & 2030
Fig. 35 Global Gene Synthesis Market, : Region Movement Analysis
Fig. 36 North America Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 37 U.S. Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 38 Canada Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 39 Europe Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 41 UK Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 42 France Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 43 Italy Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 44 Spain Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 45 Denmark Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 46 Sweden Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 47 Norway Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 49 Japan Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 50 China Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 51 India Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 52 Australia Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 53 Thailand Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 54 South Korea Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 55 Latin America Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 56 Brazil Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 57 Mexico Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 58 Argentina Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 60 South Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 62 UAE Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 63 Kuwait Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 64 Ansoff Matrix
Fig. 65 Market differentiators
Fig. 66 Key company market share analysis, 2022
Fig. 67 Company market position analysis
Fig. 68 Competitive dashboard analysis
Fig. 69 Regional network map
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain - Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Gene Synthesis, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Gene Synthesis Market, : Method Movement Analysis
Fig. 17 Global Gene Synthesis Market, for Solid - phase Synthesis, 2018 - 2030 (USD Million)
Fig. 18 Global Gene Synthesis Market, for Chip - based Synthesis, 2018 - 2030 (USD Million)
Fig. 19 Global Gene Synthesis Market, for PCR - based Enzyme Synthesis, 2018 - 2030 (USD Million)
Fig. 20 Global Gene Synthesis Market, for Services, Movement Analysis
Fig. 21 Global Gene Synthesis Market, for Antibody DNA Synthesis, 2018 - 2030 (USD Million)
Fig. 22 Global Gene Synthesis Market, for Viral DNA Synthesis, 2018 - 2030 (USD Million)
Fig. 23 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
Fig. 24 Global Gene Synthesis Market, for Application, Movement Analysis
Fig. 25 Global Gene Synthesis Market, for Gene & Cell Therapy Development, 2018 - 2030 (USD Million)
Fig. 26 Global Gene Synthesis Market, for Vaccine Development, 2018 - 2030 (USD Million)
Fig. 27 Global Gene Synthesis Market, for Disease Diagnosis, 2018 - 2030 (USD Million)
Fig. 28 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
Fig. 29 Global Gene Synthesis Market, for End - use, Movement Analysis
Fig. 30 Global Gene Synthesis Market, for Biotechnology and pharmaceutical companies, 2018 - 2030 (USD Million)
Fig. 31 Global Gene Synthesis Market, for Academic and government research institutes, 2018 - 2030 (USD Million)
Fig. 32 Global Gene Synthesis Market, for Contract research organizations, 2018 - 2030 (USD Million)
Fig. 33 Regional Marketplace: Key Takeaways
Fig. 34 Regional Outlook, 2022 & 2030
Fig. 35 Global Gene Synthesis Market, : Region Movement Analysis
Fig. 36 North America Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 37 U.S. Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 38 Canada Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 39 Europe Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 41 UK Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 42 France Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 43 Italy Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 44 Spain Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 45 Denmark Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 46 Sweden Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 47 Norway Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 49 Japan Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 50 China Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 51 India Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 52 Australia Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 53 Thailand Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 54 South Korea Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 55 Latin America Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 56 Brazil Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 57 Mexico Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 58 Argentina Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 60 South Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 62 UAE Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 63 Kuwait Gene Synthesis Market, 2018 - 2030 (USD Million)
Fig. 64 Ansoff Matrix
Fig. 65 Market differentiators
Fig. 66 Key company market share analysis, 2022
Fig. 67 Company market position analysis
Fig. 68 Competitive dashboard analysis
Fig. 69 Regional network map
